
Savaria Co. (TSE:SIS – Free Report) – Research analysts at Scotiabank upped their FY2027 earnings per share (EPS) estimates for shares of Savaria in a research note issued on Wednesday, August 19th. Scotiabank analyst J. Goldman now forecasts that the company will earn $1.51 per share for the year, up from their prior forecast of $1.50. The consensus estimate for Savaria’s current full-year earnings is $1.20 per share.
Savaria (TSE:SIS – Get Free Report) last released its quarterly earnings data on Wednesday, August 5th. The company reported C$0.35 EPS for the quarter. The business had revenue of C$245.78 million for the quarter. Savaria had a net margin of 9.27% and a return on equity of 13.41%.
Check Out Our Latest Research Report on Savaria
Savaria Stock Performance
Shares of SIS stock opened at C$28.54 on Friday. Savaria has a 12 month low of C$20.10 and a 12 month high of C$31.95. The stock has a market capitalization of C$2.06 billion, a P/E ratio of 23.59, a PEG ratio of 42.72 and a beta of 1.04. The company has a current ratio of 1.72, a quick ratio of 0.91 and a debt-to-equity ratio of 29.43. The firm’s 50 day moving average is C$29.82 and its 200 day moving average is C$28.14.
Insiders Place Their Bets
In other Savaria news, Director Les Teague sold 5,000 shares of the firm’s stock in a transaction dated Friday, June 26th. The stock was sold at an average price of C$28.92, for a total transaction of C$144,600.00. Also, Director Peter Allen Drutz sold 9,736 shares of the company’s stock in a transaction dated Saturday, June 6th. The stock was sold at an average price of C$29.00, for a total value of C$282,344.00. Following the completion of the transaction, the director owned 95,251 shares of the company’s stock, valued at C$2,762,279. The trade was a 9.27% decrease in their ownership of the stock. In the last 90 days, insiders have sold 81,747 shares of company stock worth $2,448,032. Insiders own 17.45% of the company’s stock.
Savaria Company Profile
Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.
Read More
- Five stocks we like better than Savaria
- Coherent Stock Is Cooling Off Just as Its AI Thermal Opportunity Heats Up
- Moderna’s 177% Surge Has Investors Asking What Comes Next
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
Receive News & Ratings for Savaria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Savaria and related companies with MarketBeat.com's FREE daily email newsletter.
